{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:47:19Z","timestamp":1761587239150,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.intimp.2022.109406","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T13:12:35Z","timestamp":1667913155000},"page":"109406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"PA","title":["Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes"],"prefix":"10.1016","volume":"113","author":[{"given":"Alireza","family":"Milani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elnaz","family":"Agi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hassan Pouriayevali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdieh","family":"Motamedi-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Motevalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Bolhassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109406_b0005","unstructured":"WHO HIV-aids Data 2020. https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids (accessed on 11 April 2022)."},{"issue":"9","key":"10.1016\/j.intimp.2022.109406_b0010","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/vaccines9091026","article-title":"Current status of HIV-1 vaccines","volume":"9","author":"Hargrave","year":"2021","journal-title":"Vaccines"},{"issue":"38","key":"10.1016\/j.intimp.2022.109406_b0015","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.vaccine.2011.07.043","article-title":"Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection: Workshop in dendritic cell-based vaccine clinical trials in HIV-1","volume":"29","author":"Garc\u00eda","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.intimp.2022.109406_b0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"Lu","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2022.109406_b0025","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"Garc\u00eda","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109406_b0030","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e32834f33e8","article-title":"mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients","volume":"26","author":"Van Gulck","year":"2012","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.intimp.2022.109406_b0035","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","article-title":"Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load","volume":"44","author":"L\u00e9vy","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"30","key":"10.1016\/j.intimp.2022.109406_b0040","doi-asserted-by":"crossref","first-page":"48401","DOI":"10.18632\/oncotarget.10269","article-title":"Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma","volume":"7","author":"Su","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.intimp.2022.109406_b0045","doi-asserted-by":"crossref","first-page":"e0211490","DOI":"10.1371\/journal.pone.0211490","article-title":"Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses","volume":"14","author":"Zheng","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109406_b0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2017.09.005","article-title":"Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity","volume":"191","author":"Milani","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2022.109406_b0055","article-title":"Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients","volume":"2011","author":"Bray","year":"2011","journal-title":"Clin. Developm. Immunol."},{"key":"10.1016\/j.intimp.2022.109406_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/864720","article-title":"A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo","volume":"2013","author":"Arribillaga","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2022.109406_b0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2217\/imt-2018-0105","article-title":"Heat-shock proteins in diagnosis and treatment: An overview of different biochemical and immunological functions","volume":"11","author":"Milani","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.intimp.2022.109406_b0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2119\/molmed.2014.00058","article-title":"Human myocardium releases heat shock protein 27 (HSP27) after global ischemia: The proinflammatory effect of extracellular HSP27 through toll-like receptor (TLR)-2 and TLR4","volume":"20","author":"Jin","year":"2014","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2022.109406_b0075","doi-asserted-by":"crossref","first-page":"14287","DOI":"10.1096\/fj.202001389RR","article-title":"Heat shock protein 27 immune complex altered signaling and transport (ICAST): novel mechanisms of attenuating inflammation","volume":"34","author":"Shi","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2022.109406_b0080","unstructured":"A. De, C. Miller-Graziano, Use of Hsp27 as an anti-inflammatory agent, Google Patents (2001) US20010049357A1."},{"issue":"18","key":"10.1016\/j.intimp.2022.109406_b0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/14760584.2019.1640117","article-title":"Novel prime-boost vaccine strategies against HIV-1","volume":"18","author":"Excler","year":"2019","journal-title":"Expert Review of Vaccines"},{"issue":"10","key":"10.1016\/j.intimp.2022.109406_b0090","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/iub.2107","article-title":"Gene and protein delivery using four cell penetrating peptides for HIV-1 vaccine development","volume":"71","author":"Rostami","year":"2019","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.intimp.2022.109406_b0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.14712\/fb2016062030103","article-title":"Generation of GFP native protein for detection of its intracellular uptake by cell-penetrating peptides","volume":"62","author":"Kadkhodayan","year":"2016","journal-title":"Folia Biol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109406_b0100","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/1567201814666171129210654","article-title":"Antiviral effects of saffron and its major ingredients","volume":"15","author":"Soleymani","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.intimp.2022.109406_b0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2007.00552.x","article-title":"Phagocytosis and antigen presentation in dendritic cells","volume":"219","author":"Savina","year":"2007","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2022.109406_b0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.immuni.2008.08.001","article-title":"Dendritic cells in vivo: a key target for a new vaccine science","volume":"29","author":"Steinman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2022.109406_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00281-016-0588-7","article-title":"Dendritic cells and parasites: from recognition and activation to immune response instruction","volume":"39","author":"Motran","year":"2017","journal-title":"Sem. Immunopathol."},{"key":"10.1016\/j.intimp.2022.109406_b0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2017.07.012","article-title":"Dendritic cell recruitment and activation in autoimmunity","volume":"85","author":"Sozzani","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2022.109406_b0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/v12010024","article-title":"Dendritic cells in HIV\/SIV prophylactic and therapeutic vaccination","volume":"12","author":"Ko","year":"2019","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.intimp.2022.109406_b0130","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2217\/fon.12.125","article-title":"Dendritic cell-based vaccines: barriers and opportunities","volume":"8","author":"Cintolo","year":"2012","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109406_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.2010.00967.x","article-title":"Immunization delivered by lentiviral vectors for cancer and infectious diseases","volume":"239","author":"Hu","year":"2011","journal-title":"Immunol. Rev."},{"issue":"43","key":"10.1016\/j.intimp.2022.109406_b0140","doi-asserted-by":"crossref","first-page":"31688","DOI":"10.1074\/jbc.M704129200","article-title":"Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling","volume":"282","author":"Bendz","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2022.109406_b0145","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1586\/14760584.2013.836909","article-title":"VLPs and particle strategies for cancer vaccines","volume":"12","author":"Ungaro","year":"2013","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.intimp.2022.109406_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1524","article-title":"CD91-dependent programming of T-helper cell responses following heat shock protein immunization","volume":"2","author":"Pawaria","year":"2011","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2022.109406_b0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<196::AID-IMMU196>3.0.CO;2-4","article-title":"Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects","volume":"29","author":"Chassin","year":"1999","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109406_b0160","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.4049\/jimmunol.175.10.6560","article-title":"Functional analysis of HIV type 1 Nef reveals a role for PAK2 as a regulator of cell phenotype and function in the murine dendritic cell line, DC2.4","volume":"175","author":"Mann","year":"2005","journal-title":"J. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2022.109406_b0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.vaccine.2003.07.009","article-title":"The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector","volume":"22","author":"Maccormac","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.intimp.2022.109406_b0170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109406_b0175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1567201816666190923152914","article-title":"Combination of mechanical and chemical methods improves gene delivery in cell-based HIV vaccines","volume":"16","author":"Soleymani","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.intimp.2022.109406_b0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molimm.2019.02.016","article-title":"Modified DCs and MSCs with HPV E7 antigen and small Hsps: Which one is the most potent strategy for eradication of tumors?","volume":"108","author":"Bolhassani","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2022.109406_b0185","doi-asserted-by":"crossref","unstructured":"G. Nchinda, D. Amadu, C. Trumpfheller, O. Mizenina, K. \u00dcberla, R.M. Steinman, Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells, Proceedings of the National Academy of Sciences 107 (9) (2010) 4281\u20134286.","DOI":"10.1073\/pnas.1000621107"},{"key":"10.1016\/j.intimp.2022.109406_b0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fimmu.2017.00101","article-title":"Dendritic cell targeting effectively boosts T cell responses elicited by an HIV multiepitope DNA vaccine","volume":"8","author":"Apostolico","year":"2017","journal-title":"Front. Immunol."},{"issue":"46","key":"10.1016\/j.intimp.2022.109406_b0195","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.vaccine.2016.09.062","article-title":"Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines","volume":"34","author":"Jorritsma","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2022.109406_b0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-3083.1999.00467.x","article-title":"Relationship between interleukin-5 production and variations in eosinophil counts during HIV infection in West Africa: Influence of mycobacterium tuberculosis infection","volume":"49","author":"Diagbouga","year":"1995","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109406_b0205","first-page":"253","article-title":"Impaired interleukin-5 (IL-5) production by T cells as a prognostic marker of disease progression in human immunodeficiency virus type 1 (HIV-1)-infected children","volume":"12","author":"Resino","year":"2001","journal-title":"Eur. Cytokine Netw."},{"issue":"6","key":"10.1016\/j.intimp.2022.109406_b0210","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.157.6.2712","article-title":"Single cell analysis of IL-4 and IFN-\u03b3 production by T cells from HIV-infected individuals: decreased IFN-\u03b3 in the presence of preserved IL-4 production","volume":"157","author":"Meyaard","year":"1996","journal-title":"J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:44:16Z","timestamp":1761587056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922008906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":42,"alternative-id":["S1567576922008906"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109406","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109406"}}